455 related articles for article (PubMed ID: 25483366)
1. Calcifediol improves lipid profile in osteopenicatorvastatin-treated postmenopausal women.
Catalano A; Morabito N; Basile G; Cucinotta D; Lasco A
Eur J Clin Invest; 2015 Feb; 45(2):144-9. PubMed ID: 25483366
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships.
Kane L; Moore K; Lütjohann D; Bikle D; Schwartz JB
J Clin Endocrinol Metab; 2013 Nov; 98(11):4400-9. PubMed ID: 24030939
[TBL] [Abstract][Full Text] [Related]
3. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
[TBL] [Abstract][Full Text] [Related]
4. Effects of atorvastatin on bone mineral density (BMD) and bone metabolism in elderly males with osteopenia and mild dyslipidemia: a 1-year randomized trial.
Chen ZG; Cai HJ; Jin X; Lu JH; Wang J; Fang NY
Arch Gerontol Geriatr; 2014; 59(3):515-21. PubMed ID: 25131773
[TBL] [Abstract][Full Text] [Related]
5. Effects of Different Vitamin D Supplementation Schemes in Post-Menopausal Women: A Monocentric Open-Label Randomized Study.
Corrado A; Rotondo C; Cici D; Berardi S; Cantatore FP
Nutrients; 2021 Jan; 13(2):. PubMed ID: 33530511
[TBL] [Abstract][Full Text] [Related]
6. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.
Minisola S; Cianferotti L; Biondi P; Cipriani C; Fossi C; Franceschelli F; Giusti F; Leoncini G; Pepe J; Bischoff-Ferrari HA; Brandi ML
Osteoporos Int; 2017 Nov; 28(11):3239-3249. PubMed ID: 28815282
[TBL] [Abstract][Full Text] [Related]
7. Effects of Weekly Supplementation of Cholecalciferol and Calcifediol Among the Oldest-Old People: Findings From a Randomized Pragmatic Clinical Trial.
Ruggiero C; Baroni M; Bini V; Brozzetti A; Parretti L; Zengarini E; Lapenna M; Antinolfi P; Falorni A; Mecocci P; Boccardi V
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31731651
[TBL] [Abstract][Full Text] [Related]
8. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D
Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
BMC Musculoskelet Disord; 2018 Jul; 19(1):210. PubMed ID: 29970059
[TBL] [Abstract][Full Text] [Related]
9. Is calcifediol better than cholecalciferol for vitamin D supplementation?
Quesada-Gomez JM; Bouillon R
Osteoporos Int; 2018 Aug; 29(8):1697-1711. PubMed ID: 29713796
[TBL] [Abstract][Full Text] [Related]
10. Pilot Trial of Vitamin D3 and Calcifediol in Healthy Vitamin D Deficient Adults: Does It Change the Fecal Microbiome?
Shieh A; Lee SM; Lagishetty V; Gottleib C; Jacobs JP; Adams JS
J Clin Endocrinol Metab; 2021 Nov; 106(12):3464-3476. PubMed ID: 34343292
[TBL] [Abstract][Full Text] [Related]
11. Effects of alendronate and calcifediol compared to alendronate and cholecalciferol in osteoporotic patients.
Giampà E; Di Bonito M; Ferretti V; Nuvoli G; Paoletti F; Piazzini M; Ranieri M; Tuveri MA; Vinicola V
Minerva Endocrinol; 2019 Dec; 44(4):344-350. PubMed ID: 31971357
[TBL] [Abstract][Full Text] [Related]
12. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients.
Barros X; Rodríguez NY; Fuster D; Rodas L; Esforzado N; Mazza A; Rubello D; Campos F; Tapias A; Torregrosa JV
J Nephrol; 2016 Oct; 29(5):703-9. PubMed ID: 26454858
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
Davidson MH; Rooney MW; Drucker J; Eugene Griffin H; Oosman S; Beckert M;
Clin Ther; 2009 Dec; 31(12):2824-38. PubMed ID: 20110022
[TBL] [Abstract][Full Text] [Related]
14. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
Melhem SJ; Aiedeh KM; Hadidi KA
Ann Saudi Med; 2015; 35(1):13-8. PubMed ID: 26142932
[TBL] [Abstract][Full Text] [Related]
15. Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity.
Bischoff-Ferrari HA; Dawson-Hughes B; Stöcklin E; Sidelnikov E; Willett WC; Edel JO; Stähelin HB; Wolfram S; Jetter A; Schwager J; Henschkowski J; von Eckardstein A; Egli A
J Bone Miner Res; 2012 Jan; 27(1):160-9. PubMed ID: 22028071
[TBL] [Abstract][Full Text] [Related]
16. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial.
Pérez-Castrillón JL; Dueñas-Laita A; Brandi ML; Jódar E; Del Pino-Montes J; Quesada-Gómez JM; Cereto Castro F; Gómez-Alonso C; Gallego López L; Olmos Martínez JM; Alhambra Expósito MR; Galarraga B; González-Macías J; Bouillon R; Hernández-Herrero G; Fernández-Hernando N; Arranz-Gutiérrez P; Chinchilla SP
J Bone Miner Res; 2021 Oct; 36(10):1967-1978. PubMed ID: 34101900
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.
Hansen KE; Johnson RE; Chambers KR; Johnson MG; Lemon CC; Vo TN; Marvdashti S
JAMA Intern Med; 2015 Oct; 175(10):1612-21. PubMed ID: 26237520
[TBL] [Abstract][Full Text] [Related]
18. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
Fisk CM; Theobald HE; Sanders TA
J Nutr; 2012 Jul; 142(7):1286-90. PubMed ID: 22623396
[TBL] [Abstract][Full Text] [Related]
19. Calcifediol versus vitamin D3 effects on gait speed and trunk sway in young postmenopausal women: a double-blind randomized controlled trial.
Meyer O; Dawson-Hughes B; Sidelnikov E; Egli A; Grob D; Staehelin HB; Theiler G; Kressig RW; Simmen HP; Theiler R; Bischoff-Ferrari HA
Osteoporos Int; 2015 Jan; 26(1):373-81. PubMed ID: 25369890
[TBL] [Abstract][Full Text] [Related]
20. Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women.
Tanriverdi HA; Barut A; Sarikaya S
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):63-8. PubMed ID: 15866088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
